"The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-ap"...
- Clinician Information:
Zoladex 3.6 Patient Information including How Should I Take
In this Article
- What is goserelin (Zoladex 3.6)?
- What are the possible side effects of goserelin (Zoladex 3.6)?
- What is the most important information I should know about goserelin (Zoladex 3.6)?
- What should I discuss with my healthcare provider before receiving goserelin (Zoladex 3.6)?
- How is goserelin given (Zoladex 3.6)?
- What happens if I miss a dose (Zoladex 3.6)?
- What happens if I overdose (Zoladex 3.6)?
- What should I avoid while receiving goserelin (Zoladex 3.6)?
- What other drugs will affect goserelin (Zoladex 3.6)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving goserelin (Zoladex 3.6)?
You should not receive this medication if you are allergic to goserelin or to similar hormone medications such as leuprolide (Lupron, Eligard, Viadur), nafarelin (Synarel), or ganirelix (Antagon). Do not use goserelin if you are pregnant or breast-feeding.
To make sure you can safely use goserelin, tell your doctor if you have any of these other conditions:
- osteoporosis or low bone density;
- a history of heart attack or stroke;
- risk factors for coronary artery disease (such as high blood pressure, high cholesterol, smoking, or being overweight);
- urination problems;
- a condition affecting your spine; or
- if you have abnormal bleeding that your doctor has not checked.
FDA pregnancy category X. This medication can harm an unborn baby or cause birth defects. However, goserelin is sometimes given to pregnant women being treated for advanced breast cancer. Unless you are being treated for advanced breast cancer, you should not use goserelin during pregnancy.
Before receiving goserelin, you may need a pregnancy test to make sure you are not pregnant. Tell your doctor right away if you become pregnant during treatment. Use effective birth control while you are using this medication and for at least 12 weeks after your treatment ends.
If you are a premenopausal woman, goserelin should cause your periods to stop during treatment. However, you must still use an effective barrier form of birth control (such as a condom or diaphragm with spermicide gel or inserts). Hormonal forms of contraception (such as birth control pills, injections, implants, skin patches, and vaginal rings) may not be effective during your treatment with goserelin.
After you stop using goserelin, you should begin having regular periods again. Call your doctor if your normal periods do not return within 12 weeks after your goserelin treatment ends.
It is not known whether goserelin passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using goserelin.
Goserelin can decrease bone mineral density, which may increase your risk of developing osteoporosis. This risk may be greater if you smoke, drink alcohol frequently, have a family history of osteoporosis, or use certain drugs such as seizure medications or steroids. Talk to your doctor about your individual risk of bone loss.
How is goserelin given (Zoladex 3.6)?
Goserelin is given in a tiny implant that is inserted through a needle injected under the skin of your upper stomach. You will receive this injection in a clinic or doctor's office.
You are not likely to be able to feel the implant through your skin, and it should not cause pain or discomfort. The implant will dissolve in your body over time.
A new goserelin implant is usually injected every 28 days, but the timing of your dose may be different if you are also receiving chemotherapy. Follow your doctor's instructions. It is very important to receive your goserelin injections on time each month.
If you are a premenopausal woman, you should stop having menstrual periods during treatment with goserelin. Call your doctor if you still have regular periods. Missing a dose can cause breakthrough bleeding.
While your hormone levels are adjusting to goserelin, you may notice increased symptoms or new symptoms of your condition. This should be only temporary during the first few weeks of treatment. Tell your doctor if your symptoms do not improve after several weeks of using goserelin.
Your blood sugar may need to be checked while using goserelin, even if you are not diabetic. You may need other blood tests at your doctor's office. Visit your doctor regularly.
This medication can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you are using goserelin.
Additional Zoladex 3.6 Information
Report Problems to the Food and Drug Administration
Find support and advances in treatment.